Clinical Pharmacology of Incretin Therapies for Type 2 Diabetes Mellitus: Implications for Treatment

Based on the pharmacokinetic and therapeutic characteristics described in previously published Phase III and IV studies of incretin therapies, these agents may provide an option for the management of T2DM.